Provider review
Omzo review
Its 'discount' pricing is actually a price increase — $199 shown as a deal off $179
Semaglutide is listed at "$179, currently offered at $199" and tirzepatide at "$259, currently offered at $349" — in both cases the discount is more expensive than the price it discounts. Follow-up months run $299 and $399.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Omzo's pricing is published rather than hidden, but the pricing itself contains a real error or misleading framing — both its 'current' semaglutide and tirzepatide prices are actually higher than the figures they're shown discounted from — and no individual clinician is named anywhere.
Omzo is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want a provider that displays a LegitScript seal
- You want a single account covering GLP-1s alongside hormone, sexual, hair, and skin health
- You want brand-name Ozempic or Zepbound as an alternative to compounded options
Look elsewhere if
- You want pricing copy that makes sense — the 'discounted' figures shown are actually higher than the base price listed next to them
- You want a named clinician disclosed before starting
- You want a named compounding pharmacy — only generic 'independent, state-licensed' language is given
What it actually costs
What they advertise
Semaglutide listed at '$179, currently offered at $199' for the first month (follow-up $299); tirzepatide listed at '$259, currently offered at $349' (follow-up $399) — both 'current' figures are actually higher than the base price shown beside them.
What you actually pay, month to month
$299/month ongoing for semaglutide, $399/month ongoing for tirzepatide in the Terms and Conditions, after the first-month rate.
The commitment trap
The 'currently offered at' figures ($199, $349) are presented as if discounted from $179 and $259, but are actually higher than those base figures — read as a price increase, not a promotion.
Money you will meet later
- Brand-name Ozempic runs $1,299/month and Zepbound $1,399/month as alternatives to compounded options
Checked live on Omzo's own site at https://www.omzo.com/terms-and-conditions in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Omzo bundles in, and what it does not.
Clinician consult
Clinician guidance described as included
no individual clinician is named anywhere on the site.
Bloodwork / labs
Not published.
Follow-ups and dose changes
No cadence published.
Human support
Not published.
Injection supplies
Not published.
Shipping
Free, discreet delivery included.
Pharmacy, labs and oversight
The pharmacy
Not individually named — described only as 'independent, state-licensed' sterile compounding pharmacy.
Oversight
No cadence published.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
All 50 states in its Terms and Conditions.
The honest cons
The part they would rather you skipped
Omzo's own Terms and Conditions price semaglutide and tirzepatide as 'currently offered at' figures that are actually higher than the base prices shown right beside them — a real pricing-copy error or misleading discount framing either way.
- Its own 'discounted' pricing figures are actually higher than the base prices shown next to them
- No individual clinician named anywhere on the site
- No named compounding pharmacy, only generic language
- Shares near-identical legal boilerplate and brand-drug pricing with a different reviewed provider, Peptivo, suggesting a shared white-label platform
None of this is unique to Omzo — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. Omzo is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Omzo's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Omzo's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.